Reuters logo
BRIEF-Ritter Pharma says on March 1, co held type C informational meeting with U.S. FDA
March 13, 2017 / 9:40 PM / 8 months ago

BRIEF-Ritter Pharma says on March 1, co held type C informational meeting with U.S. FDA

March 13 (Reuters) - Ritter Pharmaceuticals Inc

* Ritter pharmaceuticals - on march 1, co held type c informational meeting with u.s. Fda to discuss development plans and its current clinical trial for treatment of lactose intolerance

* Focus of meeting was to gain feedback about company s statistical analysis plan

* Ritter pharma-to modify aspects of its sap, including modifying its primary endpoint to combine abdominal pain with relevant secondary endpoints to establish abdominal composite score Source text for Eikon: (bit.ly/2nh4dDp) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below